Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke
Table 3
Effect of resveratrol on the weight status and on the body mass index.
Weight status
Resveratrol 100 mg group
Resveratrol 200 mg group
Control group
Number of patients
%
Number of patients
%
Number of patients
%
Normal weight
17
20.99
11
20.00
17
18.48
Overweight
33
40.74
23
41.82
36
39.13
Class I obesity
18
22.22
12
21.82
22
23.91
Class II obesity
9
11.11
7
12.73
12
13.04
Class III obesity
4
4.94
2
3.64
5
5.43
BMI average (initial)
29.47 ± 4.26
29.50 ± 4.27
29.95 ± 4.49
Normal weight
21
25.93
15
27.27
17
18.48
Overweight
33
40.74
24
43.64
36
39.13
Class I obesity
16
19.75
9
16.36
23
25.00
Class II obesity
8
9.88
5
9.09
11
11.96
Class II obesity
3
3.70
2
3.64
5
5.43
BMI average (at six months)
27.97 ± 4.44
27.56 ± 4.28
29.42 ± 4.72
ES
0.35
0.45
0.12
Normal weight
28
34.57
19
34.55
18
19.57
Overweight
36
44.44
25
45.45
36
39.13
Class I obesity
10
12.35
6
10.91
22
23.91
Class II obesity
5
6.17
4
7.27
11
11.96
Class III obesity
2
2.47
1
1.82
5
5.43
BMI average (at 12 months)
26.75 ± 4.12
25.77 ± 4.13
29.31 ± 4.55
ES
0.27
0.42
0.02
Values are represented as mean ± SD ( patients in the resveratrol 100 mg group; patients in the resveratrol 200 mg group; and patients in the control group); versus initial value; <0.05 versus control group value.
